MAX Chat
Taro Pharmaceutical Industries Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
29.47 | 27.8 | 6% | 73.42 | -59.86% |
| P/S |
|
2.52 | 4.08 | -38.21% |
|
|
| P/BV |
|
0.8854 | 10.5 | -91.57% |
|
|
| P/FCF |
|
20.66 | 36.15 | -42.85% |
|
|
| Ev/Ebitda |
|
23.28 | 18.1 | 28.61% |
|
|
| Ev/S |
|
1.95 | 4.39 | -55.62% |
|
|
| Ev/FCF |
|
15.67 | 44.96 | -65.15% |
|
|
| E/P |
|
0.0334 | 0.2726 | -87.75% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
3/10
|
8.36 | 21.38 | -60.9% | 17.68 | -52.71% |
| ROE |
|
3.06 | -70.06 | -104.36% |
|
|
| ROA |
|
2.51 | 8.48 | -70.42% |
|
|
| ROIC |
|
-0.34 | 21.56 | -101.58% |
|
|
| ROS |
|
8.56 | 10.99 | -22.1% |
|
|
| ROCE |
|
1.2 | 83.76 | -98.57% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0371 | 2.68 | -98.62% | 0.0248 | +49.51% |
| Nеt Debt/Ebitda |
|
-6.9 | 2.83 | -343.56% |
|
|
| Debt/Ratio |
|
0.000902 | 0.2908 | -99.69% |
|
|
| Debt/Equity |
|
0.2058 | 14.91 | -98.62% |
|
|
| Debt/Net Income |
|
0.0362 | 4.41 | -99.18% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.35 | -100% | 15.13 | -100% |
| Number of years of dividend growth |
|
1 | 6.36 | -84.27% | ||
| DSI |
|
0.5 | 0.7342 | -31.9% |
|
|
| Average dividend growth |
|
0 | -7.77 | -100% |
|
|
| Average percentage for 5 years |
|
15.13 | 1.3 | 1061.18% |
|
|
| Average percentage for payments |
|
342.14 | 42.93 | 697.03% |
|
|
| Difference from average difference in sector |
|
-1.35 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-2.45 | 1169.02 | -100.21% | ||
| Growth impulse Ebitda in 5 years |
|
-83.56 | 152.6 | -154.76% | ||
| Growth impulse Net Income in 5 years |
|
-77.92 | 10125.27 | -100.77% | ||
| Growth impulse FCF in 5 years |
|
-67.83 | 5781.13 | -101.17% | ||
| Growth impulse EPS in 5 years |
|
-77.43 | 13603.5 | -100.57% |
IP Score
4.33/10
